The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glasebrook, A. L.
Right arrow Articles by MacDonald, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glasebrook, A. L.
Right arrow Articles by MacDonald, H. R.

The Journal of Immunology, Vol 130, Issue 4 1552-1555, Copyright © 1983 by American Association of Immunologists

ARTICLES

Monoclonal anti-Lyt-2 antibodies block the activation of cytolytic T lymphocyte precursors

AL Glasebrook and HR MacDonald

In the present study, we reinvestigated the effects of anti-Lyt-2 monoclonal antibodies (mAb) on the generation of H-2K/D-specific Lyt-2+ cytolytic T lymphocytes (CTL). A sensitive limiting dilution microculture system supplemented with a source of interleukin 2 (IL 2) was employed to provide a minimal estimation of the frequency of CTL precursors (CTL-P) in normal spleen or mixed leukocyte culture (MLC) populations. The addition of anti-Lyt-2 (but not anti-Thy-1) mAb at culture initiation caused an average 78% reduction in the number of CTL- P within spleen cell populations that were activated by allogeneic stimulation. Most CTL that were generated from Lyt-2+ CTL-P in the presence of anti-Lyt-2 mAb were not inhibited in cytolysis by such mAb, whereas the majority of CTL generated in the absence of anti-Lyt-2 were inhibitable. In contrast to normal spleen, the frequency of (operationally defined) CTL-P that had been activated for 5 days in primary MLC was unaffected by the presence of anti-Lyt-2 mAb. Collectively, these results demonstrate that anti-Lyt-2 mAb are capable of inhibiting the antigen-dependent activation of normal splenic precursors of Lyt-2+ CTL. The fact that IL 2 could not overcome the inhibition suggests that anti-Lyt-2 mAb may have affected the expression of IL 2 receptors as a direct consequence of inhibiting CTL- P antigen recognition.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
A. Sharland, A. Patel, J. H. Lee, A. E. Cestra, S. Saidman, and G. L. Waneck
Genetically Modified HLA Class I Molecules Able to Inhibit Human NK Cells Without Provoking Alloreactive CD8+ CTLs
J. Immunol., April 1, 2002; 168(7): 3266 - 3274.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. S. N. Lamouse-Smith, D. S. Dougall, and S. A. McCarthy
Cytokine Requirements for Production of a Novel Anti-CD8-Resistant CTL Population
J. Immunol., October 15, 1999; 163(8): 4160 - 4167.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. A. McCarthy, M. S. Mainwaring, D. S. Dougall, and E. S. Lamouse-Smith
Activation Requirements, Lytic Mechanism, and Development of a Novel Anti-CD8-Resistant CTL Population
J. Immunol., March 15, 1998; 160(6): 2715 - 2724.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.